The DESiGN trial (DEtection of Small for Gestational age Neonate), evaluating the effect of the Growth Assessment Protocol (GAP): study protocol for a randomised controlled trial.
Customised growth centiles
Health economics
Implementation research
Small-for-gestational-age foetus
Stillbirth
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
04 Mar 2019
04 Mar 2019
Historique:
received:
08
05
2018
accepted:
06
02
2019
entrez:
6
3
2019
pubmed:
6
3
2019
medline:
27
6
2019
Statut:
epublish
Résumé
Stillbirth rates in the United Kingdom (UK) are amongst the highest of all developed nations. The association between small-for-gestational-age (SGA) foetuses and stillbirth is well established, and observational studies suggest that improved antenatal detection of SGA babies may halve the stillbirth rate. The Growth Assessment Protocol (GAP) describes a complex intervention that includes risk assessment for SGA and screening using customised fundal-height growth charts. Increased detection of SGA from the use of GAP has been implicated in the reduction of stillbirth rates by 22%, in observational studies of UK regions where GAP uptake was high. This study will be the first randomised controlled trial examining the clinical efficacy, health economics and implementation of the GAP programme in the antenatal detection of SGA. In this randomised controlled trial, clusters comprising a maternity unit (or National Health Service Trust) were randomised to either implementation of the GAP programme, or standard care. The primary outcome is the rate of antenatal ultrasound detection of SGA in infants found to be SGA at birth by both population and customised standards, as this is recognised as being the group with highest risk for perinatal morbidity and mortality. Secondary outcomes include antenatal detection of SGA by population centiles, antenatal detection of SGA by customised centiles, short-term maternal and neonatal outcomes, resource use and economic consequences, and a process evaluation of GAP implementation. Qualitative interviews will be performed to assess facilitators and barriers to implementation of GAP. This study will be the first to provide data and outcomes from a randomised controlled trial investigating the potential difference between the GAP programme compared to standard care for antenatal ultrasound detection of SGA infants. Accurate information on the performance and service provision requirements of the GAP protocol has the potential to inform national policy decisions on methods to reduce the rate of stillbirth. Primary registry and trial identifying number: ISRCTN 67698474 . Registered on 2 November 2016.
Sections du résumé
BACKGROUND
BACKGROUND
Stillbirth rates in the United Kingdom (UK) are amongst the highest of all developed nations. The association between small-for-gestational-age (SGA) foetuses and stillbirth is well established, and observational studies suggest that improved antenatal detection of SGA babies may halve the stillbirth rate. The Growth Assessment Protocol (GAP) describes a complex intervention that includes risk assessment for SGA and screening using customised fundal-height growth charts. Increased detection of SGA from the use of GAP has been implicated in the reduction of stillbirth rates by 22%, in observational studies of UK regions where GAP uptake was high. This study will be the first randomised controlled trial examining the clinical efficacy, health economics and implementation of the GAP programme in the antenatal detection of SGA.
METHODS/DESIGN
METHODS
In this randomised controlled trial, clusters comprising a maternity unit (or National Health Service Trust) were randomised to either implementation of the GAP programme, or standard care. The primary outcome is the rate of antenatal ultrasound detection of SGA in infants found to be SGA at birth by both population and customised standards, as this is recognised as being the group with highest risk for perinatal morbidity and mortality. Secondary outcomes include antenatal detection of SGA by population centiles, antenatal detection of SGA by customised centiles, short-term maternal and neonatal outcomes, resource use and economic consequences, and a process evaluation of GAP implementation. Qualitative interviews will be performed to assess facilitators and barriers to implementation of GAP.
DISCUSSION
CONCLUSIONS
This study will be the first to provide data and outcomes from a randomised controlled trial investigating the potential difference between the GAP programme compared to standard care for antenatal ultrasound detection of SGA infants. Accurate information on the performance and service provision requirements of the GAP protocol has the potential to inform national policy decisions on methods to reduce the rate of stillbirth.
TRIAL REGISTRATION
BACKGROUND
Primary registry and trial identifying number: ISRCTN 67698474 . Registered on 2 November 2016.
Identifiants
pubmed: 30832739
doi: 10.1186/s13063-019-3242-6
pii: 10.1186/s13063-019-3242-6
pmc: PMC6398257
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
154Subventions
Organisme : Tommy's Baby Charity
ID : MQATAVR
Organisme : Stillborn and Neonatal Death Charity (GB)
ID : RG1011/16
Organisme : Guy's and St Thomas' Charity (GB)
ID : MAJ150704
Organisme : NIDDK NIH HHS
ID : R01 DK103246
Pays : United States
Organisme : Department of Health
ID : NIHR-KMF-2012-01-29
Pays : United Kingdom
Investigateurs
Peter Brocklehurst
(P)
Susan Tebbs
(S)
Caroline Doré
(C)
Paul Seed
(P)
Louisa Delaney
(L)
Janet Cresswell
(J)
Sarah Petty
(S)
Bini Ajay
(B)
Beverley Wright
(B)
Hannah O'Donnell
(H)
Melissa Howard
(M)
Emma Wayman
(E)
Paula Galea
(P)
Mandish Dhanjal
(M)
Elisa Iaschi
(E)
Vanessa Hodge
(V)
Hiran Samarage
(H)
Sunder Chita
(S)
Raffaele Napolitano
(R)
Iris Tsikimi
(I)
Fiona Ghalustians
(F)
Spyros Bakalis
(S)
Simona Cicero
(S)
Elisabeth Peregrine
(E)
Lyndsey Smith
(L)
Deepa Janga
(D)
Renata Hutt
(R)
Edwin Chandraharan
(E)
Références
Br J Obstet Gynaecol. 1999 Apr;106(4):309-17
pubmed: 10426236
BJOG. 2001 Aug;108(8):830-4
pubmed: 11510708
Lancet. 1992 Feb 1;339(8788):283-7
pubmed: 1346292
BJOG. 2005 Aug;112(8):1026-33
pubmed: 16045513
BMJ. 2005 Nov 12;331(7525):1113-7
pubmed: 16236774
Am J Obstet Gynecol. 2006 Apr;194(4):1042-9
pubmed: 16580294
Clin Obstet Gynecol. 2006 Jun;49(2):257-69
pubmed: 16721105
Arch Dis Child Fetal Neonatal Ed. 2007 Jul;92(4):F277-80
pubmed: 17251224
BJOG. 2007 Apr;114(4):474-7
pubmed: 17378820
Lancet. 2007 Nov 17;370(9600):1715-25
pubmed: 18022035
BMC Pregnancy Childbirth. 2008 Jan 08;8:1
pubmed: 18179721
BJOG. 2008 Oct;115(11):1397-404
pubmed: 18823489
Radiology. 1991 Oct;181(1):129-33
pubmed: 1887021
BMJ. 2008 Oct 22;337:a1937
pubmed: 18945728
Ultrasound Obstet Gynecol. 2009 May;33(5):599-608
pubmed: 19291813
Am J Obstet Gynecol. 2009 Jul;201(1):28.e1-8
pubmed: 19576372
Paediatr Perinat Epidemiol. 2011 Jan;25(1):2-10
pubmed: 21133964
Paediatr Perinat Epidemiol. 2011 Jan;25(1):11-6
pubmed: 21133965
Lancet. 2011 May 14;377(9778):1703-17
pubmed: 21496907
Aust N Z J Obstet Gynaecol. 2012 Feb;52(1):78-82
pubmed: 22309365
BMJ. 2012 Mar 16;344:e1552
pubmed: 22427307
BJOG. 2012 Jun;119(7):848-56
pubmed: 22469096
J Matern Fetal Neonatal Med. 2013 Jan;26(1):16-20
pubmed: 22882114
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
BMJ. 2013 Jan 24;346:f108
pubmed: 23349424
J Epidemiol Community Health. 2014 Feb;68(2):101-2
pubmed: 24022816
J Epidemiol Community Health. 2014 Feb;68(2):123-9
pubmed: 24072744
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
BMC Med Res Methodol. 2014 Apr 22;14:54
pubmed: 24755392
Cochrane Database Syst Rev. 2014 May 16;(5):CD008549
pubmed: 24830409
Acta Obstet Gynecol Scand. 2014 Aug;93(8):727-40
pubmed: 24834960
Lancet Diabetes Endocrinol. 2014 Oct;2(10):781-92
pubmed: 25009082
Lancet. 2014 Sep 6;384(9946):869-79
pubmed: 25209488
J Matern Fetal Neonatal Med. 2015;28(17):2080-3
pubmed: 25327177
Pregnancy Hypertens. 2014 Jan;4(1):34-40
pubmed: 26104252
Lancet. 2015 Nov 21;386(10008):2089-2097
pubmed: 26360240
Ultrasound Obstet Gynecol. 2016 Nov;48(5):602-606
pubmed: 27854393
PLoS Med. 2017 Jan 24;14(1):e1002220
pubmed: 28118360
Semin Fetal Neonatal Med. 2017 Jun;22(3):193-198
pubmed: 28215929
Br J Obstet Gynaecol. 1986 Mar;93(3):212-6
pubmed: 3964595
J Pediatr. 1967 Aug;71(2):159-63
pubmed: 6029463
Stat Med. 1998 Feb 28;17(4):407-29
pubmed: 9496720